Discovery of novel phthalimide analogs : synthesis, antimicrobial and antitubercular screening with molecular docking studies
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
Discovery of novel phthalimide analogs ; Vol. 15, 2016
EXCLI journal ; Vol. 15, 2016
- Klassifikation
-
Medizin, Gesundheit
- Urheber
-
Rateb, Heba S.
Ahmed, Hany E. A.
Ahmed, Sahar
Ihmaid, Saleh
Afifi, Tarek H.
- Handle
-
2003/35855
- URN
-
urn:nbn:de:101:1-20170317198
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
- 14.08.2025, 10:44 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Rateb, Heba S.
- Ahmed, Hany E. A.
- Ahmed, Sahar
- Ihmaid, Saleh
- Afifi, Tarek H.
Ähnliche Objekte (12)
Indole bearing thiadiazole analogs: synthesis, β-glucuronidase inhibition and molecular docking study
Design, synthesis, docking study and cytotoxic activity evaluation of some novel letrozole analogs
Design, Synthesis, Antitumor Activity and Molecular Docking Study of Novel 5-Deazaalloxazine Analogs
The discovery of potential acetylcholinesterase inhibitors: A combination of pharmacophore modeling, virtual screening, and molecular docking studies
Synthesis, antiplasmodial activity and in silico molecular docking study of pinocembrin and its analogs
Boosting the antimicrobial performance based on new fused spirothiazolidine framework analogs
Discovery of potential FGFR3 inhibitors via QSAR, pharmacophore modeling, virtual screening and molecular docking studies against bladder cancer
New Combretastatin Analogs as Anticancer Agents: Design, Synthesis, Microtubules Polymerization Inhibition, and Molecular Docking Studies
3D-QSAR, Docking, ADME/Tox studies on Flavone analogs reveal anticancer activity through Tankyrase inhibition
Automation of antimicrobial activity screening
Benchmarking AlphaFold ‐enabled molecular docking predictions for antibiotic discovery
Cepharanthine analogs mining and genomes of Stephania accelerate anti-coronavirus drug discovery
Indole bearing thiadiazole analogs: synthesis, β-glucuronidase inhibition and molecular docking study
Design, synthesis, docking study and cytotoxic activity evaluation of some novel letrozole analogs
Design, Synthesis, Antitumor Activity and Molecular Docking Study of Novel 5-Deazaalloxazine Analogs
The discovery of potential acetylcholinesterase inhibitors: A combination of pharmacophore modeling, virtual screening, and molecular docking studies
Synthesis, antiplasmodial activity and in silico molecular docking study of pinocembrin and its analogs
Boosting the antimicrobial performance based on new fused spirothiazolidine framework analogs
Discovery of potential FGFR3 inhibitors via QSAR, pharmacophore modeling, virtual screening and molecular docking studies against bladder cancer
New Combretastatin Analogs as Anticancer Agents: Design, Synthesis, Microtubules Polymerization Inhibition, and Molecular Docking Studies
3D-QSAR, Docking, ADME/Tox studies on Flavone analogs reveal anticancer activity through Tankyrase inhibition
Automation of antimicrobial activity screening
Benchmarking AlphaFold ‐enabled molecular docking predictions for antibiotic discovery
Cepharanthine analogs mining and genomes of Stephania accelerate anti-coronavirus drug discovery
Indole bearing thiadiazole analogs: synthesis, β-glucuronidase inhibition and molecular docking study
Design, synthesis, docking study and cytotoxic activity evaluation of some novel letrozole analogs
Design, Synthesis, Antitumor Activity and Molecular Docking Study of Novel 5-Deazaalloxazine Analogs
The discovery of potential acetylcholinesterase inhibitors: A combination of pharmacophore modeling, virtual screening, and molecular docking studies
Synthesis, antiplasmodial activity and in silico molecular docking study of pinocembrin and its analogs
Boosting the antimicrobial performance based on new fused spirothiazolidine framework analogs
Discovery of potential FGFR3 inhibitors via QSAR, pharmacophore modeling, virtual screening and molecular docking studies against bladder cancer
New Combretastatin Analogs as Anticancer Agents: Design, Synthesis, Microtubules Polymerization Inhibition, and Molecular Docking Studies
3D-QSAR, Docking, ADME/Tox studies on Flavone analogs reveal anticancer activity through Tankyrase inhibition
Automation of antimicrobial activity screening
Benchmarking AlphaFold ‐enabled molecular docking predictions for antibiotic discovery